Resultats de la cerca - Wang, Cheng-I
- Mostrar 1 - 20 resultats de 31
- Anar a la pàgina següent
-
1
-
2
-
3
-
4
-
5
A novel human anti-interleukin-1β neutralizing monoclonal antibody showing in vivo efficacy per Goh, Angeline XH, Bertin-Maghit, Sebastien, Ping Yeo, Siok, Ho, Adrian, Derks, Heidi, Mortellaro, Alessandra, Wang, Cheng-I
Publicat 2014Text -
6
Structural basis for blocking PD-1-mediated immune suppression by therapeutic antibody pembrolizumab per Na, Zhenkun, Yeo, Siok Ping, Bharath, Sakshibeedu R, Bowler, Matthew W, Balıkçı, Esra, Wang, Cheng-I, Song, Haiwei
Publicat 2017Text -
7
Effective in vivo therapeutic IgG antibody against VP3 of enterovirus 71 with receptor-competing activity per Jia, Qiang, Ng, Qingyong, Chin, Wenjie, Meng, Tao, Chow, Vincent Tak Kwong, Wang, Cheng-I, Kwang, Jimmy, He, Fang
Publicat 2017Text -
8
A Reverse Binding Motif that Contributes to Specific Protease Inhibition by Antibodies per Schneider, Eric L., Lee, Melody S., Baharuddin, Aida, Goetz, David H., Farady, Christopher J., Ward, Mick, Wang, Cheng-I, Craik, Charles S.
Publicat 2011Text -
9
Solution Structure of a Phytocystatin from Ananas comosus and Its Molecular Interaction with Papain per Irene, Deli, Chung, Tse-Yu, Chen, Bo-Jiun, Liu, Ting-Hang, Li, Feng-Yin, Tzen, Jason T. C., Wang, Cheng-I, Chyan, Chia-Lin
Publicat 2012Text -
10
A Preclinical Assessment Of (89)Zr-atezolizumab Identifies A Requirement For Carrier Added Formulations Not Observed With (89)Zr-C4 per Moroz, Anna, Chia-Yin, Lee, Wang, Yung-hua, Hsiao, Jeffrey C., Sevillano, Natalia, Truillet, Charles, Craik, Charles S., Fong, Lawrence, Wang, Cheng-I, Evans, Michael J.
Publicat 2018Text -
11
A potent neutralizing antibody with therapeutic potential against all four serotypes of dengue virus per Xu, Meihui, Zuest, Roland, Velumani, Sumathy, Tukijan, Farhana, Toh, Ying Xiu, Appanna, Ramapraba, Tan, Ern Yu, Cerny, Daniela, MacAry, Paul, Wang, Cheng-I, Fink, Katja
Publicat 2017Text -
12
Publisher Correction: A potent neutralizing antibody with therapeutic potential against all four serotypes of dengue virus per Xu, Meihui, Zuest, Roland, Velumani, Sumathy, Tukijan, Farhana, Toh, Ying Xiu, Appanna, Ramapraba, Tan, Ern Yu, Cerny, Daniela, MacAry, Paul, Wang, Cheng-I, Fink, Katja
Publicat 2018Text -
13
Protective Capacity of the Human Anamnestic Antibody Response during Acute Dengue Virus Infection per Xu, Meihui, Züst, Roland, Toh, Ying Xiu, Pfaff, Jennifer M., Kahle, Kristen M., Davidson, Edgar, Doranz, Benjamin J., Velumani, Sumathy, Tukijan, Farhana, Wang, Cheng-I, Fink, Katja
Publicat 2016Text -
14
An analysis of isoclonal antibody formats suggests a role for measuring PD-L1 with low molecular weight PET radiotracers per Wei, Junnian, Wang, Yung-hua, Lee, Chia Yin, Truillet, Charles, Oh, David Y., Xu, Yichen, Ruggero, Davide, Flavell, Robert R., VanBrocklin, Henry F., Seo, Youngho, Craik, Charles S., Fong, Lawrence, Wang, Cheng-I, Evans, Michael J.
Publicat 2020Text -
15
Humanized Mouse as a Tool to Predict Immunotoxicity of Human Biologics per Yong, Kylie Su Mei, Her, Zhisheng, Tan, Sue Yee, Tan, Wilson Wei Sheng, Liu, Min, Lai, Fritz, Heng, Shi Min, Fan, Yong, Chang, Kenneth Tou En, Wang, Cheng-I, Chan, Jerry Kok Yen, Chen, Jianzhu, Chen, Qingfeng
Publicat 2020Text -
16
Chikungunya Virus Neutralization Antigens and Direct Cell-to-Cell Transmission Are Revealed by Human Antibody-Escape Mutants per Lee, Chia Yin, Kam, Yiu-Wing, Fric, Jan, Malleret, Benoit, Koh, Esther G. L., Prakash, Celine, Huang, Wen, Lee, Wendy W. L., Lin, Cui, Lin, Raymond T. P., Renia, Laurent, Wang, Cheng-I, Ng, Lisa F. P., Warter, Lucile
Publicat 2011Text -
17
Plasmablasts During Acute Dengue Infection Represent a Small Subset of a Broader Virus-specific Memory B Cell Pool per Appanna, Ramapraba, KG, Srinivasan, Xu, Mei Hui, Toh, Ying-Xiu, Velumani, Sumathy, Carbajo, Daniel, Lee, Chia Yin, Zuest, Roland, Balakrishnan, Thavamalar, Xu, Weili, Lee, Bernett, Poidinger, Michael, Zolezzi, Francesca, Leo, Yee Sin, Thein, Tun Linn, Wang, Cheng-I, Fink, Katja
Publicat 2016Text -
18
Comprehensive engineering of a therapeutic neutralizing antibody targeting SARS-CoV-2 spike protein to neutralize escape variants per Kuramochi, Taichi, Gan, Siok Wan, Ho, Adrian W.S., Wang, Bei, Kageji, Nagisa, Nambu, Takeru, Iida, Sayaka, Okuda-Miura, Momoko, Chia, Wei Shan, Yeo, Chiew Ying, Chen, Dan, Lee, Wen-Hsin, Ngoh, Eve Zi Xian, Mohd Salleh, Siti Nazihah, Wang, Cheng-I, Igawa, Tomoyuki, Shimada, Hideaki
Publicat 2022Text -
19
Cross-reactive dengue human monoclonal antibody prevents severe pathologies and death from Zika virus infections per Kam, Yiu-Wing, Lee, Cheryl Yi-Pin, Teo, Teck-Hui, Howland, Shanshan W., Amrun, Siti Naqiah, Lum, Fok-Moon, See, Peter, Kng, Nicholas Qing-Rong, Huber, Roland G., Xu, Mei-Hui, Tan, Heng-Liang, Choo, Andre, Maurer-Stroh, Sebastian, Ginhoux, Florent, Fink, Katja, Wang, Cheng-I, Ng, Lisa F.P., Rénia, Laurent
Publicat 2017Text -
20
Resistance of SARS-CoV-2 variants to neutralization by convalescent plasma from early COVID-19 outbreak in Singapore per Wang, Bei, Goh, Yun Shan, Prince, Tessa, Ngoh, Eve Zi Xian, Salleh, Siti Nazihah Mohd, Hor, Pei Xiang, Loh, Chiew Yee, Fong, Siew Wai, Hartley, Catherine, Tan, Seow-Yen, Young, Barnaby Edward, Leo, Yee-Sin, Lye, David C., Maurer-Stroh, Sebastian, Ng, Lisa F. P., Hiscox, Julian A., Renia, Laurent, Wang, Cheng-I
Publicat 2021Text